| Zeit | Aktuelle Nachrichten
| | Leser | Medien |
|---|
| 15.05.
| Traders Get Bullish on Shares of Somaxon Pharmaceuticals, Shares Up 6.3% | | 6 | SmarTrend |
| 10.05.
| Somaxon Pharmaceuticals, Inc. - 10-Q, Quarterly Report | | - | SEC Filings |
| 10.05.
| Somaxon Pharmaceuticals Reports First Quarter 2012 Financial Results | | 22 | Business Wire |
| Conference call scheduled today at 8:30 a.m. ET (5:30 a.m. PT);
Simultaneous webcast at http://investors.somaxon.com/eventdetail.cfm
Somaxon...
Mehr lesen zu:
Somaxon Pharmaceuticals Reports First Quarter 2012 Financial Results | |
| 04.05.
| Watch for Continued Losses in Shares of Somaxon Pharmaceuticals | | 1 | SmarTrend |
| 30.04.
| Somaxon Pharmaceuticals to Report First Quarter 2012 Results and Conduct Conference Call on Thursday, May 10 | | 22 | Business Wire |
| Somaxon Pharmaceuticals, Inc. (NASDAQ: SOMX), a specialty pharmaceutical
company, today announced that it will release its first quarter ended
March 31, 2012 financial...
Mehr lesen zu:
Somaxon Pharmaceuticals to Report First Quarter 2012 Results and Conduct Conference Call on Thursday, May 10 | |
| 30.04.
| Somaxon, CJ CheilJedang sign Silenor commercialization agreement | | 1 | Pharma Bus Review |
| 27.04.
| Somaxon and CJ CheilJedang Announce Silenor® Collaboration in South Korea | | 36 | Business Wire |
| Somaxon Pharmaceuticals, Inc. (Nasdaq: SOMX) and CJ CheilJedang
Corporation today announced that they have entered into an exclusive
collaboration under which CJ CheilJedang...
Mehr lesen zu:
Somaxon and CJ CheilJedang Announce Silenor® Collaboration in South Korea | |
| 19.04.
| Shares of Somaxon Pharmaceuticals Fall to a New 52-Week Low | | - | SmarTrend |
| 18.04.
| Shares of Somaxon Pharmaceuticals Has Fallen Below Previous 52-Week Low | | 1 | SmarTrend |
| 17.04.
| Watch for Continued Losses in Shares of Somaxon Pharmaceuticals | | - | SmarTrend |
| 09.03.
| Somaxon Pharmaceuticals, Inc. - 10-K, Annual Report | | 1 | SEC Filings |
| 08.03.
| Somaxon Reports Financial Results for Full Year and Fourth Quarter Ended December 31, 2011 | | 49 | Business Wire |
| Conference call scheduled today at 4:30 p.m. ET (1:30 p.m. PT);Simultaneous
webcast at http://investors.somaxon.com/eventdetail.cfm
Somaxon...
Mehr lesen zu:
Somaxon Reports Financial Results for Full Year and Fourth Quarter Ended December 31, 2011 | |
| 27.02.
| Somaxon Pharmaceuticals to Report Full Year and Fourth Quarter 2011 Results and Conduct Conference Call on Thursday, March 8 | | 39 | Business Wire |
| Somaxon Pharmaceuticals, Inc. (NASDAQ: SOMX), a specialty pharmaceutical
company, today announced that it will release its full year and fourth
quarter 2011 financial...
Mehr lesen zu:
Somaxon Pharmaceuticals to Report Full Year and Fourth Quarter 2011 Results and Conduct Conference Call on Thursday, March 8 | |
| 22.02.
| Paladin and Somaxon Announce Filing of New Drug Submission for Silenor(R) | | 57 | MarketWire |
| MONTREAL, CANADA and SAN DIEGO, CALIFORNIA -- (Marketwire) -- 02/22/12 -- Paladin Labs Inc. (TSX: PLB) and Somaxon Pharmaceuticals, Inc. (NASDAQ: SOMX) today announced that Paladin has filed a New...
Mehr lesen zu:
Paladin and Somaxon Announce Filing of New Drug Submission for Silenor(R) | |
| 22.02.
| Paladin and Somaxon Announce Filing of New Drug Submission for Silenor® | | 54 | Business Wire |
| Paladin Labs Inc. (TSX:PLB) and Somaxon Pharmaceuticals, Inc. (Nasdaq:
SOMX) today announced that Paladin has filed a New Drug Submission (NDS)
that has been accepted...
Mehr lesen zu:
Paladin and Somaxon Announce Filing of New Drug Submission for Silenor® | |
| 19.12.
| UPDATE 1-Somaxon to explore strategic options, cut jobs | | 1 | Reuters.com |
| 19.12.
| Somaxon (SOMX) Hires Advisor to Seek Strategic Alternatives | | 1 | StreetInsider.com |
| 19.12.
| Somaxon Pharmaceuticals Hires Financial Advisor to Assist in Seeking Strategic Alternatives | | 65 | Business Wire |
| Somaxon Pharmaceuticals, Inc. (Nasdaq: SOMX), a specialty pharmaceutical
company, today announced that it has hired Stifel Nicolaus Weisel as a
strategic advisor. Stifel...
Mehr lesen zu:
Somaxon Pharmaceuticals Hires Financial Advisor to Assist in Seeking Strategic Alternatives | |
